Public, NASDAQ:IMGN
NASDAQ Global Market
ImmunoGen, Inc - SWOT Analysis - http://www.companiesandmarkets.com adds new report
Date: Thu, 27 Nov 2008 02:01:46 GMT
Tags:
ImmunoGen, Inc - SWOT Analysis - http://www.companiesandmarkets.com adds new report
Live-PR.com (Pressemitteilung) - Nov 27, 2008
Live-PR.com (Pressemitteilung) - Nov 27, 2008
Datamonitor´s ImmunoGen, Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company´s key business structure and ...
IMGN: To Present At Lazard Capital Healthcare Conference @ 13:10 ET [delayed]
Date: Tue, 18 Nov 2008 17:05:46 GMT
Tags:
IMGN: To Present At Lazard Capital Healthcare Conference @ 13:10 ET [delayed]
Trading Markets (press release) - Nov 18, 2008
Trading Markets (press release) - Nov 18, 2008
Ridgeland, MS, NOV 18, 2008 (EventX/Knobias.com via COMTEX) -- IMGN | Quote | Chart | News | PowerRating -- Company representatives of ImmunoGen Inc (NasdaqNM: IMGN | Quote | Chart | News ...
ImmunoGen, Inc - SWOT Analysis - New Research Report on Companies and Markets
Date: Sat, 15 Nov 2008 16:32:21 GMT
Tags:
ImmunoGen, Inc - SWOT Analysis - New Research Report on Companies and Markets
Live-PR.com (Pressemitteilung) - Nov 15, 2008
Live-PR.com (Pressemitteilung) - Nov 15, 2008
ImmunoGen, Inc Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products ...
Premium Company Profile - ImmunoGen - New Research Report on Companies and Markets
Date: Fri, 14 Nov 2008 21:29:53 GMT
Tags:
Premium Company Profile - ImmunoGen - New Research Report on Companies and Markets
Live-PR.com (Pressemitteilung) - Nov 14, 2008
Live-PR.com (Pressemitteilung) - Nov 14, 2008
ImmunoGen is a biopharmaceutical company aimed at developing targeted anticancer compounds. Over the years, the company gained vast expertise in the field of immunoconjugates resulting in the ...
ImmunoGen, Inc. Announces Webcast of Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference
Date: Tue, 11 Nov 2008 11:46:37 GMT
Tags:
ImmunoGen, Inc. Announces Webcast of Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference
Centre Daily Times - Nov 11, 2008
Centre Daily Times - Nov 11, 2008
WALTHAM, Mass. — ImmunoGen, Inc. (Nasdaq: IMGN) today announced that its presentation at the Lazard Capital Markets 5th Annual Healthcare Conference will be webcast live. The presentation is ...
IMMUNOGEN INC Files SEC form 8-K, Financial Statements and Exhibits (EDGAR Online)
Date: Fri, 14 Nov 2008 14:36:38 Etc/GMT
Tags:
ImmunoGen, Inc. Announces Webcast of Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference (Business Wire)
Date: Tue, 11 Nov 2008 11:30:00 Etc/GMT
Tags:
WALTHAM, Mass.----ImmunoGen, Inc. today announced that its presentation at the Lazard Capital Markets 5th Annual Healthcare Conference will be webcast live. The presentation is scheduled to begin at 1:10 pm EST on November 18, 2008, and will be given at The St.
ImmunoGen, Inc. Appoints James J. O'Leary, MD, as Vice President and Chief Medical Officer (Business Wire)
Date: Mon, 10 Nov 2008 11:30:00 Etc/GMT
Tags:
WALTHAM, Mass.----ImmunoGen, Inc. , a biopharmaceutical company that develops targeted anticancer therapeutics, today announced that the Company has appointed James J. OâLeary, MD, as Vice President and Chief Medical Officer.
ImmunoGen Falls Near Support (Zacks.com)
Date: Thu, 6 Nov 2008 20:21:19 Etc/GMT
Tags:
IMMUNOGEN INC Financials (EDGAR Online Financials)
Date: Wed, 5 Nov 2008 14:04:16 Etc/GMT
Tags: